Loading...

乳腺及外科專科服務

科研文章

Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial
Chow LWC, Yip AYS, Chu WP, Loo WT, Toi M J Steroid Biochem Mol Biol 2011; 25(1-2): 1
Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation
Chanplakorn N, Chanplakorn P, Suzuki T, Ono K, Wang L, Chan MS, Wing L, Yiu CC, Chow LWC, Sasano H Horm Cancer 2011;2: 73-81
Effect of Sanguisorba officinalis L on breast cancer growth and angiogenesis
Wang ZY, Loo WTY, Wang N, Chow LWC, Wang DM, Han F, Zheng X, Chen JP Expert Opin Ther Targets 2012; Suppl 1: S79-89
Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1
Shibahara Y, Miki Y, Onodera Y, Hata S, Chan MSM, Yiu CCP, Loo WTY, Nakamura Y, Akahira JI, Ishida T, Abe K, Hirakawa H, Chow LWC, Suzuki T, Ouchi N, Sasano H J Pathol 2012; 227: 357-366
Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique
Takada M, Sugimoto M, Ohno S, Kuroi K, Sato N, Bando H, Masuda N, Iwata H, Kondo M, Sasano H, Chow LWC, Inamoto T, Naito Y, Tomita M, Toi M Breast Cancer Res Treat 2012; 34: 661-670
New therapies in HER2-positive breast cancer: a major step towards a cure of the disease?
Awada A, Bozovic-Spasojevic I, Chow LWC Cancer Treat Rev 2012; 38: 494-504
Association of matrix metalloproteinase (MMP)-1, 3, 9, interleukin (IL)-2, 8 and cyclooxygenase (COX)-2 gene polymorphisms with chronic periodontitis in a Chinese population
Li GY, Yue Y, Tian Y, Li JL, Wang M, Liang H, Liao PX, Loo WTY, Cheung MNB, Chow LWC Cytokine 2012; Nov;60(2):552-
LMTK3 is implicated in endocrine resistance via multiple signaling pathways
Stebbing J, Filipovic A, Lit LC, Blighe K, Grothey A, Xu Y, Miki Y, Chow LWC, Coombes RC, Sasano H, Shaw JA, Giamas G Oncogene 2012; Aug 6
Decreased Expression of C-erbB-2 and CXCR4 in Breast Cancer after Primary Chemotherapy
Yang SX, Loo WTY, Chow LWC, Yang XH, Zhan Y, Fan LJ, Zhang F, Li C, Wang QL, Xiao HL, Wu JL, Bian XW, Jiang J J of Translational Medicine 2012;10, Suppl 1: S3
Overexpression of epithelial growth factor receptor (EGFR) predict better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer
Tang YQ, Zhu L, Li YF, Ji J, Li JF, Yuan F, Wang DB, Chen WG, Huang O, Chen XS, Wu JY, Shen KW, Loo WTY, Chow LWC J of Translational Medicine 2012;10, Suppl 1: S4
Comparing serum levels of cardiac biomarkers in cancer patients receiving chemotherapy and subjects with chronic periodontitis
Loo WTY, Yue Y, Fan CB, Bai LJ, Dou YD, Wang M, Liang H, Cheung MNB, Chow LWC, Li J, Tian Y, Qing L J of Translational Medicine 2012;10, Suppl 1: S5
Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis
Wei W, Hu H, Tan HS, Chow LWC, Yip AYS, Loo WTY J of Translational Medicine 2012;10, Suppl 1: S6
Emodin affects ERCC1 expression in breast cancer cells
Fu JM, Zhou J, Shi J, Xie JS, Huang L, Yip AYS, Loo WTY, Chow LWC, Ng ELY J of Translational Medicine 2012;10, Suppl 1: S7
Gene polymorphism and protein of human pro- and anti-inflammatory cytokines in Chinese healthy subjects and chronic periodontitis patients
Loo WTY, Fan CB, Bai LJ, Yue Y, Dou YD, Wang M, Liang H, Cheung MNB, Chow LWC, Li JL, Tian Y, Qing L J of Translational Medicine 2012;10, Suppl 1: S8
Gene polymorphism and protein of human pro- and anti-inflammatory cytokines in Chinese healthy subjects and chronic periodontitis patients
Loo WTY, Fan CB, Bai LJ, Yue Y, Dou YD, Wang M, Liang H, Cheung MNB, Chow LWC, Li JL, Tian Y, Qing L J of Translational Medicine 2012;10, Suppl 1: S8
Mouse model of plasma cell mastitis
Yu JJ, Bao SL, Yu SL, Zhang DQ, Loo WTY, Chow LWC, Su L, Cui Z, Chen K, Ma LQ, Zhang N, Yu H, Yang YZ, Dong Y, Yip AYS, Ng ELY J of Translational Medicine 2012;10, Suppl 1: S11
Using association rules mining to explore pattern of Chinese medicinal formulae (prescription) in treating and preventing breast cancer recurrence and metastasis
He Y, Zheng X, Sit C, Loo WTY, Wang ZY, Xie T, Jia B, Ye QB, Tsui KC, Chow LWC, Chen JP J of Translational Medicine 2012;10, Suppl 1: S
Minimally invasive video-assisted thyroidectomy for the early-stage differential thyroid carcinoma
Yu JJ, Bao SL, Yu SL, Zhang DQ, Loo WTY, Chow LWC, Su L, Cui Z, Chen K, Ma LQ, Zhang N, Yu H, Yang WZ, Dong Y, Yip AYS, Ng ELY J of Translational Medicine 2012;10, Suppl 1: S13
具抗药性乳腺癌病人的组合性用药治疗方案及其疗效和监察的探讨
Chow LWC, Yip AYS, Liu Q, Loo WTY The 15th Annual Meeting of Chinese Society of Clinical Oncology (CSCO) Educational Book, People’s Medical Publishing House, 2012;243-242
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference
Toi M, Benson JR, Winer EP, Forbes JF, von Minckwitz G, Golshan M, Robertson JF, Sasano H, Cole BF, Chow LWC, Pegram MD, Han W, Huang CS, Ikeda T, Kanao S, Lee ES, Noguchi S, Ohno S, Partridge AH, Rouzier R, Tozaki M, Sugie T, Yamauchi A, Inamoto T Breast Cancer Res Treat 2012, 36(3):919-26
Prevention of oncological diseases: primary and secondary prevention
Chow LWC, Yip AYS, Ng ELY Int J Biol Markers  2012;Dec, 27;27(4):e337-43
The clinical trials of the Organisation for Oncology and Translational Research (OOTR)
Chow LWC, Toi M Int J Biol Markers  2012;Dec, 27;27(4):e314-21
Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis
Xu C, Zhao J, Loo WT, Hao L, Wang M, Cheung MNB, Dou Y, Yip AYS, Ng ELY, Chow LWC, Liu Q Int J Biol Markers  2012;Dec, 27;27(4):e314-21
Evaluation of the psychological and biological changes of patients diagnosed with benign and malignant breast tumors.
Bai LJ, Liu Q, Wang M, Loo WTY, Cheng RWY, Chow LWC, Cheung MNB, Wei KYR, Yip AYS, Ng ELY Int J Biol Markers  2012;Dec, 7;27(4):e322-30
Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients – an immunohistochemical study of cd8+ and foxp3+ using double immunostaining with correlation to the pathobiological response of the patients
Chan MSM, Wang L, Felizola SJA, Ueno T, Toi M, Loo WTY, Chow LWC, Suzuki T, Sasano H Int J Biol Markers  2012;Dec 1, 27;27(4):e295-304
Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Wolff AC, Lazar AA, Bondarenko I, Garin AM, Brincat S, Chow LWC, Sun Y, Neskovic-Konstantinovic Z, Guimaraes RC, Fumoleau P, Chan A, Hachemi S, Strahs A, Cincotta M, Berkenblit A, Krygowski M, Kang LL, Moore L, Hayes DF J Clin Oncol 2012;Dec 1
Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II – III invasive breast cancer: the OOTR-N001 study
Chow LWC, Tung SY, Ng TY, Im SA, Lee MH, Yip AYS, Toi M, Glück S Expert Opin Investig Drugs 2013;Mar, 22(3):299-307
Association of cytokines, high sensitive C-reactive protein, VEGF and beta-defensin-1 gene polymorphisms and their protein expressions with chronic periodontitis in the Chinese population
Tian Y, Li JL, Hao L, Yue Y, Wang M, Loo WTY, Cheung MNB, Chow LWC, Liu Q, Yip AYS, Ng ELY, Chow CY Int J Biol Markers  2013;April, 23;28(1):e100-e107
Application of biomarkers to sentinel lymph node biopsy for the management of breast cancer
Liu Q, Loo WTY, Yip AYS, Chow LWC, Ng ELY, Cheung MNB Chinese Journal of Breast Disease 2013;Mar 2,